Changes to Brazilian legislation regarding the use of RSHO™ cannabis products has created waves in the medical marijuana community around the world. RSHO™ produces a high-quality medical grade cannabis oil that is abundant in the cannabinoid CBD (cannabidiol). This natural botanical product is being imported into Brazil for four indications: epilepsy, Parkinson’s disease, chronic pain conditions and now cancer. These products are created from hemp oil and lack the THC content that leads to the “high” that is incorrectly attributed to medical marijuana products.
According to the National Institutes of Health and the National Cancer Institute, an estimated 1,658,370 cases of cancer were diagnosed in 2015 alone. Another 589,430 of those who were diagnosed would have died from cancer. In the same year, the most common cancers were breast, lung, prostate, bronchus, colon, rectum and bladder cancer as well as non-Hodgkin lymphoma, thyroid, kidney, renal pelvis, endometrial, leukemia and pancreatic cancer. Out of every 100,000 people, 454.8 will receive a new cancer diagnosis.
The number of men who die from cancer is significantly higher than the number of women, and the risk of cancer mortality is highest among African American men and lowest among Asian and Pacific Islander women. Nearly 40 percent of all men and women will receive a cancer diagnosis at some point in their lives. A shocking 15,780 of those individuals are diagnosed between the ages of 0 and 19 and another 1,960 of those children and adolescents diagnosed with cancer will die. Cancer is the leading cause of death around the world, and South America is among the most common world regions for cancer diagnosis.